Glycosylation is one of the most important post-translational modifications in biological systems.
INTRODUCTION
6 endoglycosidases in our method, the quantitative assessment of six N-glycan types at glycopeptides was 138 achieved and the sex types of N-glycan were classified as following: non-fucosylated high 139 mannose/hybrid, non-fucosylated bi-antennary, non-fucosylated tri-antennary, core fucosylated high 140 mannose/hybrid, core fucosylated bi-antennary and core fucosylated bi/tri-antennary type glycans (Fig.   141 1b).
142
Our method also includes a novel enrichment strategy. Previously, GalT1 Y298L was used to label the 143 O-linked β-N-acetylglucosamine (GlcNAc) glycopeptide with GalNAz 27 . We discovered that the GalT1 144 Y298L could effectively label the N-GlcNAc (on average 95.3%) as shown in Supplementary Fig. 4 .
145
After the N-linked glycopeptides were modified with GalNAz, and covalently linked with 146 photocleavable biotin through click reaction, the unlabeled peptides and other reagents were removed by 147 extensive washing with urea and organic buffer. The PC biotin alkyne was selected for our method 148 development because ultraviolet irradiation is a milder condition to release the labeled glycopeptides, 149 when compared with chemical methods that use strong reductive hydrazine or oxidizing regents 28 .
150
Irradiation with 365 nm ultraviolet light efficiently recovered glycopeptides from the agarose streptavidin 151 beads, with almost all glycopeptide released within 15 min ( Supplementary Fig. 5 ).
152

Validating the Glyco-TQ method on the standard glycoprotein IgG1 Fc 153
We first tested our approach using an immunoglobulin G1 (IgG1), containing one fragment 154 crystallizable region (Fc fragments) and antigen-binding fragments (F(ab')2 fragment). It has one fixed 155 N-glycosylated site at Asn297 of the Fc fragment while glycan occupancy on the F(ab')2 fragments are 156 reported to be near 20% 29 . To obtain one standard N-glycoprotein with one fixed glycosylated site, IgG1 7 type, core fucosylated high mannose/hybrid type, core fucosylated bi-antennary type and core 168 fucosylated bi/tri-antennary type glycan. The MS spectra of enriched glycopeptides and their 169 corresponding extracted-ion chromatograms are shown in the Fig. 2c . The comparison of the proportion 170 of glycan types based upon our Glyco-TQ method and MALDI-MS detection is shown in Fig. 2d . The 171 high mannose and hybrid glycan type was not detected using either methods, showing the high specificity
172
of Endo-H. As for the bi-antennary glycans released by Endo-S, the proportion of the core fucosylated 173 bi-antennary glycan is 93.9% using our Glyco-TQ method and 90.5% using MALDI-MS detection; the 174 proportion of the non-fucosylated bi-antennary is 6.1% using our Glyco-TQ method versus 9.5% using 175 MALDI-MS detection. The proportion of the core fucosylated bi-antennary from our method is higher 176 than using MALDI-MS detection (93.9% versus 90.5%), which may be due to their different ionization 177 modes. The Endo-F3 did not release the core fucosylated bisecting bi-antennary glycans and non-178 fucosylated bi-antennary type glycans (showing only with minor activity when compared with tri-179 antennary glycans) ( Supplementary Fig. 4 ) 30 . Only 3.3% of non-fucosylated glycans were released by 180 the Endo-F3 in these experiments. In conclusion, our Glyco-TQ method quantitatively revealed glycan 181 type and linkage of IgG1 Fc.
182
Identification of N-glycopeptides from MCF7 cells 183
Detection of endogenous and native N-linked GlcNAc glycopeptides. Similar to endoglycosidases,
184
Endo-β-N-acetylglucosaminidase (ENGase) acts as a de-glycosylation enzyme for the misfolding 185 proteins in the cytosol 31 . We first applied our enrichment method to enrich the endogenously and native 186 existing N-linked GlcNAc glycopeptides from MCF7 total cell lysates in absence of added any 187 endoglycosidase ( Supplementary Fig. 6 ). Our enrichment strategy yielded 71 N-linked glycopeptides 188 that mapped to consensus N-glycosylated sequences (Asn-X-Ser-Thr-Cys) and that were detected with 189 modification of one N-linked GlcNAc residue (peptide-GlcNAc) ( Supplementary Table 3 ). At the same 190 time, we also detected 63 O-linked GlcNAc modified peptides, which are located in the nucleus and 191 cytoplasm by gene ontology (GO) analysis ( Supplementary Table 4 ). Caution should be taken when 
194
Detection of N-glycopeptides from MCF7 cells. To verify our enrichment strategy, we applied the 195 three endoglycosidases (H, S, F3) to help us enrich all the high mannose, hybrid, bi-and tri-antennary 196 complex linked glycopeptides ( Supplementary Fig. 7 ). To evaluate the reproducibility of our enrichment 8 method, we performed three biological replicates with MCF-7 protein cell lysates and found 73% 198 glycopeptides were identified in at least two replicates ( Supplementary Fig. 8 ). We compared the 199 glycopeptide and non-glycopeptide fractions in each parallel replicate, and showed that the specificity of 200 our method is 55.4%. Our performance was better than the specificity of previously boronic acid and 201 ZIC-HILIC enrichment method 8 . After N-glycan was released by the endoglycosidase, the core fucose 202 was retained on the core GlcNAc residue, which allowed us to simultaneously distinguish the non-203 fucosylated and core fucosylated peptides. In total, 1090 N-glycopeptides were detected, including 916 204 non-fucosylated and 174 core fucosylated glycopeptide, corresponding to 504 glycoproteins 205 (Supplementary Table 5 ). There were 116 glycopeptides with co-occurrence of the non-fucosylated and 206 core fucosylated glycopeptides ( Supplementary Fig. 9 ). As well, 58 glycopeptides were detected with 207 only core fucosylated type glycans. Amino acid frequencies of sequences surrounding the N-glycosylated 208 site are shown in Supplementary Fig. 10 for both the canonical and atypical N-linked glycopeptides. The
209
above was carried out using the stepped fragmentation strategy. When the normalized collision energy 210 (NCE) was set to 15, the fuc-GlcNAc linkage was prone to cleavage, which resulted in the parent ion 211 and fucose neutral loss-ion as the highest peaks ( Supplementary Fig. 11 ). For example, one MS/MS 212 spectrum of atypical motif glycopeptide with sequence ISVN#NVLPVFDNLMQQK was identified with 213 one core fucose as shown in the Fig. 3 . In addition, the glycopeptides with common glycan tag (GlcNAc-
214
GalNAzPCt) allowed help us to identify the glycopeptides with two glycosylated sites (Supplementary 215 Fig. 12 ), overcoming significant challenges posed for their identification when using the intact 216 glycopeptide method (5-7 KDa) 32 .
217
Applying the Glyco-TQ method to analyze glycopeptides of MCF7 cell line 218
Quantitative micro-heterogeneity of glycopeptides and glycoproteins. The chemoenzymatic 219 strategy allowed us to quantify the N-linked glycan dynamics on specific glycopeptide. After the peptides 220 were treated with Endo-H, S and F3, we combined and enriched the glycopeptides by affinity 221 chromatography ( Fig. 1a ). Relative quantitation of isotope peaks was calculated using the intensity of 222 each peak area, which represented the proportion of each glycan type on the glycopeptide. First, we 223 evaluated whether the different endoglycosidases treatment introduced biases during the glycan releasing 224 steps. As show in Supplementary Fig. 13 , high values from correlation coefficients (the value of 225 Pearson's correlation coefficient r > 0.96) were observed between the different endoglycosidase 226 treatment after isotope labeling. Thus, we concluded that the endoglycosidase did not exhibit off-target 227 9 protease activity and so did not introduce sample bias during glycan releasing steps. In total, we 228 quantitatively detected 698 peptides that mapped to 378 proteins. All the glycopeptides and the relative 229 ratio of each glycan type are shown in Supplementary Table 6 . Almost all the non-fucosylated 230 glycopeptides (> 97%) linked with the high-mannose or hybrid glycans (Fig. 4a ), while only 2 231 glycopeptides were linked with core fucosylated hybrid glycan and more than 97% core fucosylated 232 peptides were linked with bi-and tri-antennary complex glycans (Fig. 4b) . The quantitative results 233 exhibit distinct expression profiles for six glycan types on the glycopeptide as shown in the Fig. 4c ,
234
highlighting the abundant expression of non-fucosylated high-mannose and hybrid N-glycan. We use the 235 heatmap to show the quantitative micro-heterogeneity of glycopeptide, and relative distribution of glycan 236 type present on the particular glycosylated site ( Fig. 4d-f ). For the non-fucosylated glycopeptide, 143 237 glycopeptides were only linked with high-mannose and hybrid type glycan (Fig, 4d ). Non-fucosylated 238 glycopeptides (86.3%) were linked with high-mannose and hybrid type glycan, of which their proportion 239 is larger than 50% ( Supplementary Table 6 and Fig, 4d ). Consistent with previous report, our results 240 showed that N-glycans from the MCF7 cell line were predominant of non-fucosylated high-241 mannose/hybrid type glycans 33 . That is expected as all of the glycoproteins were first linked with high 242 mannose type glycan during the biosynthesis 34 . As for the quantitative micro-heterogeneity on the protein 243 level, we studied internal connection of different glycopeptides from the same glycoprotein ( Fig. 4g-i ).
244
The distance between the connected dots represents the glycan type expressing divergence of 245 glycopeptides from the same protein. Some proteins with more than one glycosylated site, such as 246 hemicentin-1, membralin and deoxyribonuclease-2-alpha, were detected only linked with the non-247 fucosylated high-mannose and hybrid type glycans, released by Endo-H. However, the majority of 248 detected proteins with multiple glycosylated sites have differential N-glycan type profiles at each site for 249 both the non-fucosylated (Fig. 4g, h) and fucosylated glycoproteins (Fig, 4i ). Due to the massive 250 expression of non-fucosylated high-mannose and hybrid type, distribution of non-fucosylated proteins 251 was constricted to a small region ( Fig. 4g, h) , while the fucosylated glycoproteins were more widely 252 distributed, based upon the quantitative information of six N-glycan types (Fig. 4i ). We also compared 253 the location of non-fucosylated and fucosylated glycoproteins and found that more than 60% of 254 fucosylated proteins were located in the extracellular exosome while for non-fucosylated counterparts, it 255 was 39.8% ( Supplementary Fig. 14) . That result indicates the N-linked core fucose may play significant 256 roles in cell adhesion and molecular trafficking.
10
Glycoproteins related with cancer. We quantitatively detected some glycoproteins, previously 258 reported to be related with cancers. Mannose-6-phosphate receptor (M6PR), for example, can regulate 259 cell growth and motility, and it functions as a breast cancer suppressor 35 . We detected seven N-260 glycopeptides from that protein, which exhibited diverse structures on each site (Fig. 5) 269 showed heterogeneity of glycan structure and distinctive glycan profiles on each of its glycopeptides.
270
Through investigating the proportion of glycan types at each site, we could get a better understanding of 271 the expression of this glycoprotein and its glycoprotein variants, which will promote our understanding 272 of glycoprotein function in cancer.
273
DISCUSSION
274
The previously quantitative reports of glycoproteome generally focused on the difference of one 281 type glycan showed decreased complement activity and thermal stability 36,37 . However, it is challenging 282 to detect the low abundance N-glycans, including the high-mannose and hybrid structures 35 . We can 283 directly provide the proportion of high-mannose and hybrid structure with help of glycol-TQ strategy,
284
which has potential to become the routine analysis strategy for pharmaceuticals. In addition, the 285 increasing expression of the core fucosylated type on specific glycoprotein was as potential biomarkers 286 in some cancers. For example, core fucosylation of α-fetoprotein (AFP) L3 showed a significant increase 287 11 in samples from patients with hepatocellular carcinoma (HCC) than chronic hepatitis and liver cirrhosis, 288 and so has been approved for the early detection of HCC 19 . Taking advantage of our method, we can 289 provide not only the expression level of fucosylated AFP L3, but also the relative ratio between non-290 fucosylated and core fucosylated AFP L3. Combining both level of information maybe a more sensitive 291 and specific strategy to investigate the fucosylated biomarker. Additionally, the proteomic method could 
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glycopeptide with a core fucose. Moreover, the common tags on the glycopeptides will help us to identify 12 glycopeptide with atypical motifs and multiple glycosylated sites. One drawback in our research is that 318 the HCD dissociation mode couldn't directly tell the glycosite of glycopeptides 39 . The glycan-peptide 319 linkage is more labile than the amino acid linkages, which leads to the core GlcNAc residue first release 320 from peptide rather than peptide dissociation under high HCD energy. Although the N-glycopeptide 321 canonical sequon (N-X-T/S) would help us overcome most of interference of O-linked GlcNAc 322 modifications, that problem could be further resolved by using the more advanced EThcD dissociation 323 strategy, which would be able to locate the modified site from the MS/MS spectrum.
324
Site-specific intact glycopeptide methods provide information of the exact N-glycan structure on the 
340
In conclusion, we provide a chemoenzymatic method to quantify the glycan type on the glycoproteins.
341
All the procedures were with mild-conditions and result showed high specificity of enrichment through 342 affinity chromatography. We provide a new quantitative strategy based the glycan type, which allows us 343 assess the micro-heterogeneity of glycoproteins. The Glyco-TQ method has potential to be used in broad 
